Thursday Mar 27
Horizon Pharma's CEO Hosts Corporate Update Call
Good morning everyone. How are you? And thanks for being on the phone line as well.
Horizon Pharma Has Significant Growth Potential
Horizon Pharma had a truly transformational year in 2013, and is set to deliver strong revenue growth and achieve non-GAAP profitability in 2014.
Horizon Pharma to Acquire Vidara Therapeutics International Ltd. and Become Horizon Pharma plc
Horizon Pharma, Inc. and Vidara Therapeutics International Ltd. today announced they have entered into a definitive agreement under which Horizon Pharma will acquire Vidara through a reverse merger for stock and cash valued at approximately $660 million.